Open AccessP572: VENETOCLAX AND HYPOMETHYLATING AGENT COMBINATIONS FOR THE TREATMENT OF ADVANCED MYELOPROLIFERATIVE NEOPLASMS AND ACUTE MYELOID LEUKEMIA WITH EXTRAMEDULLARY DISEASE
Author(s) -
Sanber K.,
Ye K.,
Tsai H.L.,
Newman M.,
Ambinder A.,
DeZern A.,
Jain T.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845176.08161.c8
Subject(s) - venetoclax , medicine , hypomethylating agent , myeloid leukemia , oncology , myeloid , population , myelodysplastic syndromes , leukemia , gastroenterology , bone marrow , chronic lymphocytic leukemia , biochemistry , gene expression , chemistry , environmental health , dna methylation , gene